“…Thus EX and improved glycemic status in the absence of EX help treat microvascular dysfunction in patients with T2D, but likely to a different degree, through different mechanisms and differentially in microvascular beds that supply tissues that undergo exercise-induced increases in physiological activity. Evidence we have reviewed here, from humans (20, 23-25, 36, 47, 62, 67, 72, 103, 126, 145) and rodents (11,14,42,55,56,79,86,95,101,102,115), is consistent with the notion that EXinduced adaptations in microvascular structure, as well as vasodilatory and insulin signaling, occur predominantly in the skeletal muscle tissue that undergoes sufficient exercise-induced increases in activity from rest to exercise. Therefore, EX that engages the most skeletal muscle mass and recruits the most muscle fibers within each muscle (i.e., greatest increase in fiber recruitment from rest to exercise), for a sufficient duration, will induce adaptations in the greatest amount of skeletal muscle microvascular tissue.…”